Lack of TNFR2 expression by CD4+ T cells exacerbates experimental colitis

European Journal of Immunology

Volumn 39, Issue 7, 2009, Pages 1743-1753

  Shneider, Johanna Dayer ^a   Seibold, Inge ^a,b   Saxer Sekulic, Nikolina ^a,c   Paredes, Bruno E ^a,d   Saurer, Leslie ^a   Mueller, Christoph ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b RCC   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d Dermatopathologie Bodensee   (Germany)

Author keywords

CD4+ T cells; Inflammation; Intestinal immunity; TNF

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL TRANSFER; COLITIS; CONTROLLED STUDY; DISEASE SEVERITY; IMMUNOPATHOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ADOPTIVE TRANSFER; ANIMALS; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; COLITIS; COLON; DNA-BINDING PROTEINS; FLOW CYTOMETRY; GENE EXPRESSION; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-4; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 69249111346     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200839132     Document Type: Article

References (53)

1. Hehlgans, T. and Pfeffer, K., The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: Players, rules and the games. Immunology 2005. 115: 1-20.
2. Papadakis, K. A. and Targan, S. R., Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu. Rev. Med. 2000. 51: 289-298.
3. Kollias, G., Douni, E., Kassiotis, G. and Kontoyiannis, D., On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Immunol. Rev. 1999. 169: 175-194.
4. Jung, H. C., Eckmann, L., Yang, S. K., Panja, A., Fierer, J., Morzycka-Wroblewska, E. and Kagnoff, M. F., A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J. Clin. Invest. 1995. 95: 55-65.
5. Chan, K. F., Siegel, M. R. and Lenardo, J. M., Signaling by the TNF receptor superfamily and T cell homeostasis. Immunity 2000. 13: 419-422.
6. Holtmann, M. H., Schutz, M., Galle, P. R. and Neurath, M. F., Functional relevance of soluble TNF-alpha, transmembrane TNF-alpha and TNF-signal transduction in gastrointestinal diseases with special reference to inflammatory bowel diseases. Z. Gastroenterol. 2002. 40: 587-600.
7. MacEwan, D. J., TNF receptor subtype signalling: Differences and cellular consequences. Cell. Signal. 2002. 14: 477-492.
8. Aggarwal, B. B., Signalling pathways of the TNF superfamily: A double-edged sword. Nat. Rev. Immunol. 2003. 3: 745-756.
9. Holtmann, M. H. and Neurath, M. F., Differential TNF-signaling in chronic inflammatory disorders. Curr. Mol. Med. 2004. 4: 439-444.
10. Baud, V. and Karin, M., Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 2001. 11: 372-377.
11. Holtmann, M. H., Douni, E., Schutz, M., Zeller, G., Mudter, J., Lehr, H. A., Gerspach, J. et al., Tumor necrosis factor-receptor 2 is up-regulated on lamina propria T cells in Crohn's disease and promotes experimental colitis in vivo. Eur. J. Immunol. 2002. 32: 3142-3151.
12. Mizoguchi, E., Mizoguchi, A., Takedatsu, H., Cario, E., de Jong, Y. P., Ooi, C. J., Xavier, R. J. et al., Role of tumor necrosis factor receptor 2 (TNFR2) in colonic epithelial hyperplasia and chronic intestinal inflammation in mice. Gastroenterology 2002. 122: 134-144.
13. Kim, E. Y. and Teh, H. S., TNF type 2 receptor (p75) lowers the threshold of T cell activation. J. Immunol. 2001. 167: 6812-6820.
14. Tartaglia, L. A., Pennica, D. and Goeddel, D. V., Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem. 1993. 268: 18542-18548.
15. Pimentel-Muinos, F. X. and Seed, B., Regulated commitment of TNF receptor signaling: A molecular switch for death or activation. Immunity 1999. 11: 783-793.
16. Bigda, J., Beletsky, I., Brakebusch, C., Varfolomeev, Y., Engelmann, H., Bigda, J., Holtmann, H. and Wallach, D., Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity. J. Exp. Med. 1994. 180: 445-460.
17. Baxter, G. T., Kuo, R. C., Jupp, O. J., Vandenabeele, P. and MacEwan, D. J., Tumor necrosis factor-alpha mediates both apoptotic cell death and cell proliferation in a human hematopoietic cell line dependent on mitotic activity and receptor subtype expression. J. Biol. Chem. 1999. 274: 9539-9547.
18. Neurath, M. F., Fuss, I., Pasparakis, M., Alexopoulou, L., Haralambous, S., Meyer zum Buschenfelde, K. H., Strober, W. and Kollias, G., Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur. J. Immunol. 1997. 27: 1743-1750.
19. Corazza, N., Eichenberger, S., Eugster, H. P. and Mueller, C., Nonlymphocyte-derived tumor necrosis factor is required for induction of colitis in recombination activating gene (RAG)2(-/-) mice upon transfer of CD4(+)CD45RB(hi) T cells. J. Exp. Med. 1999. 190: 1479-1492.
20. Mueller, C., Tumour necrosis factor in mouse models of chronic intestinal inflammation. Immunology 2002. 105: 1-8.
21. Van Deventer, S. J., Tumour necrosis factor and Crohn's disease. Gut 1997. 40: 443-448.
22. Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D. et al., Maintenance infliximab for Crohn's disease: The ACCENT I randomised trial. Lancet 2002. 359: 1541-1549.
23. Atreya, R. and Neurath, M. F., New therapeutic strategies for treatment of inflammatory bowel disease. Mucosal Immunol. 2008. 1: 175-182.
24. Sandborn, W. J., Strategies for targeting tumour necrosis factor in IBD. Best Pract. Res. Clin. Gastroenterol. 2003. 17: 105-117.
25. Weisman, M. H., What are the risks of biologic therapy in rheumatoid arthritis? An update on safety. J. Rheumatol. Suppl. 2002. 65: 33-38.
26. Kollias, G. and Kontoyiannis, D., Role of TNF/TNFR in autoimmunity: Specific TNF receptor blockade may be advantageous to anti-TNF treatments. Cytokine Growth Factor Rev. 2002. 13: 315-321.
27. Sashio, H., Tamura, K., Ito, R., Yamamoto, Y., Bamba, H., Kosaka, T., Fukui, S. et al., Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively. Immunogenetics 2002. 53: 1020-1027.
28. Nikolaus, S., Raedler, A., Kuhbacker, T., Sfikas, N., Folsch, U. R. and Schreiber, S., Mechanisms in failure of infliximab for Crohn's disease. Lancet 2000. 356: 1475-1479.
29. Marini, M., Bamias, G., Rivera-Nieves, J., Moskaluk, C. A., Hoang, S. B., Ross, W. G., Pizarro, T. T. and Cominelli, F., TNF-alpha neutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis. Proc. Natl. Acad. Sci. USA 2003. 100: 8366-8371.
30. Mombaerts, P., Mizoguchi, E., Grusby, M. J., Glimcher, L. H., Bhan, A. K. and Tonegawa, S., Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 1993. 75: 274-282.
31. Kassiotis, G. and Kollias, G., Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: Implications for pathogenesis and therapy of autoimmune demyelination. J. Exp. Med. 2001. 193: 427-434.
32. Suvannavejh, G. C., Lee, H. O., Padilla, J., Dal Canto, M. C., Barrett, T. A. and Miller, S. D., Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG(35-55)-induced experimental autoimmune encephalomyelitis. Cell. Immunol. 2000. 205: 24-33.
33. Kollias, G., TNF pathophysiology in murine models of chronic inflammation and autoimmunity. Semin. Arthritis Rheum. 2005. 34: 3-6.
34. Ebach, D. R., Riehl, T. E. and Stenson, W. F., Opposing effects of tumor necrosis factor receptor 1 and 2 in sepsis due to cecal ligation and puncture. Shock 2005. 23: 311-318.
35. Peschon, J. J., Torrance, D. S., Stocking, K. L., Glaccum, M. B., Otten, C., Willis, C. R., Charrier, K. et al., TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J. Immunol. 1998. 160: 943-952.
36. Ebach, D. R., Newberry, R. and Stenson, W. F., Differential role of tumor necrosis factor receptors in TNBS colitis. Inflamm. Bowel Dis. 2005. 11: 533-540.
37. Kontoyiannis, D., Pasparakis, M., Pizarro, T. T., Cominelli, F. and Kollias, G., Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies. Immunity 1999. 10: 387-398.
38. Erickson, S. L., de Sauvage, F. J., Kikly, K., Carver-Moore, K., Pitts-Meek, S., Gillett, N., Sheehan, K. C. et al., Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 1994. 372: 560-563.
39. Grell, M., Zimmermann, G., Gottfried, E., Chen, C. M., Grunwald, U., Huang, D. C., Wu Lee, Y. H. et al., Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: A role for TNF-R1 activation by endogenous membrane-anchored TNF. EMBO J. 1999. 18: 3034-3043.
40. Duckett, C. S. and Thompson, C. B., The control and execution of programmed cell death: An update. Biochim. Biophys. Acta 1997. 1332: R45-R47.
41. Weiss, T., Grell, M., Hessabi, B., Bourteele, S., Muller, G., Scheurich, P. and Wajant, H., Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80: Requirement of the TNF receptor-associated factor-2 binding site. J. Immunol. 1997. 158: 2398-2404.
42. Chan, F. K., Shisler, J., Bixby, J. G., Felices, M., Zheng, L., Appel, M., Orenstein, J. et al., A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses. J. Biol. Chem. 2003. 278: 51613-51621.
43. Chung, J. Y., Park, Y. C., Ye, H. and Wu, H., All TRAFs are not created equal: Common and distinct molecular mechanisms of TRAF-mediated signal transduction. J. Cell. Sci. 2002. 115: 679-688.
44. Arch, R. H., Gedrich, R. W. and Thompson, C. B., Tumor necrosis factor receptor-associated factors (TRAFs) - a family of adapter proteins that regulates life and death. Genes Dev. 1998. 12: 2821-2830.
45. Yeh, W. C., Shahinian, A., Speiser, D., Kraunus, J., Billia, F., Wakeham, A., de la Pompa, J. L. et al., Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 1997. 7: 715-725.
46. Wallach, D., Varfolomeev, E. E., Malinin, N. L., Goltsev, Y. V., Kovalenko, A. V. and Boldin, M. P., Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 1999. 17: 331-367.
47. Zheng, L., Fisher, G., Miller, R. E., Peschon, J., Lynch, D. H. and Lenardo, M. J., Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 1995. 377: 348-351.
48. Sarin, A., Conan-Cibotti, M. and Henkart, P. A., Cytotoxic effect of TNF and lymphotoxin on T lymphoblasts. J. Immunol. 1995. 155: 3716-3718.
49. Weiss, T., Grell, M., Siemienski, K., Muhlenbeck, F., Durkop, H., Pfizenmaier, K., Scheurich, P. and Wajant, H., TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60. J. Immunol. 1998. 161: 3136-3142.
50. Chan, F. K. and Lenardo, M. J., A crucial role for p80 TNF-R2 in amplifying p60 TNF-R1 apoptosis signals in T lymphocytes. Eur. J. Immunol. 2000. 30: 652-660.
51. Li, X., Yang, Y. and Ashwell, J. D., TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 2002. 416: 345-347.
52. Winzen, R., Wallach, D., Kemper, O., Resch, K. and Holtmann, H., Selective up-regulation of the 75-kDa tumor necrosis factor (TNF) receptor and its mRNA by TNF and IL-1. J. Immunol. 1993. 150: 4346-4353.
53. Haridas, V., Darnay, B. G., Natarajan, K., Heller, R. and Aggarwal, B. B., Overexpression of the p80 TNF receptor leads to TNF-dependent apoptosis, nuclear factor-kappa B activation, and c-Jun kinase activation. J. Immunol. 1998. 160: 3152-3162.